The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| aTyr Pharma Inc | COM | 002120202 | 4,197 | 1,398,889 | SH | SOLE | 1,398,889 | 0 | 0 | ||
| Aclaris Therapeutics Inc | COM | 00461U105 | 71,837 | 4,563,962 | SH | SOLE | 4,563,962 | 0 | 0 | ||
| Aerovate Therapeutics Inc | COM | 008064107 | 13,827 | 833,927 | SH | SOLE | 833,927 | 0 | 0 | ||
| Affimed NV | COM | N01045108 | 2,943 | 1,428,571 | SH | SOLE | 1,428,571 | 0 | 0 | ||
| Akouos Inc | COM | 00973J101 | 18,932 | 2,800,566 | SH | SOLE | 2,800,566 | 0 | 0 | ||
| Altimmune Inc | COM | 02155H200 | 4,716 | 369,306 | SH | SOLE | 369,306 | 0 | 0 | ||
| Annexon Inc | COM | 03589W102 | 19,900 | 3,220,050 | SH | SOLE | 3,220,050 | 0 | 0 | ||
| Celldex Therapeutics Inc | COM | 15117B202 | 2,108 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| Cogent Biosciences Inc | COM | 19240Q201 | 60,249 | 4,038,117 | SH | SOLE | 4,038,117 | 0 | 0 | ||
| DBV Technologies SA | SPONS ADR | 002120202 | 32,540 | 9,300,000 | SH | SOLE | 9,300,000 | 0 | 0 | ||
| Dice Therapeutics Inc | COM | 23345J104 | 15,514 | 764,979 | SH | SOLE | 764,979 | 0 | 0 | ||
| Fulcrum Therapeutics Inc | COM | 359616109 | 9,708 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| GH Research PLC | ORD SH | G3855L106 | 38,731 | 3,333,154 | SH | SOLE | 3,333,154 | 0 | 0 | ||
| Gossamer Bio Inc | COM | 38341P102 | 20,929 | 1,747,000 | SH | SOLE | 1,747,000 | 0 | 0 | ||
| Immunocore Holdings PLC | ADS | 45258D105 | 4,441 | 94,605 | SH | SOLE | 94,605 | 0 | 0 | ||
| Inozyme Pharma Inc | COM | 45790W108 | 7,263 | 2,709,987 | SH | SOLE | 2,709,987 | 0 | 0 | ||
| Instil Bio Inc | COM | 45783C101 | 19,872 | 4,105,779 | SH | SOLE | 4,105,779 | 0 | 0 | ||
| LianBio | SPONS ADR | 53000N108 | 10,757 | 5,378,341 | SH | SOLE | 5,378,341 | 0 | 0 | ||
| Lyra Therapeutics Inc | COM | 55234L105 | 4,630 | 924,170 | SH | SOLE | 924,170 | 0 | 0 | ||
| Marinus Pharmaceuticals Inc | COM | 56854Q200 | 20,993 | 3,156,803 | SH | SOLE | 3,156,803 | 0 | 0 | ||
| Milestone Pharmaceuticals Inc | COM | 59935V107 | 22,293 | 2,425,737 | SH | SOLE | 2,425,737 | 0 | 0 | ||
| Pliant Therapeutics Inc | COM | 729139105 | 22,561 | 1,080,000 | SH | SOLE | 1,080,000 | 0 | 0 | ||
| Prometheus Biosciences Inc | COM | 74349U108 | 7,179 | 121,663 | SH | SOLE | 121,663 | 0 | 0 | ||
| Provention Bio Inc | COM | 74374N102 | 5,034 | 1,118,653 | SH | SOLE | 1,118,653 | 0 | 0 | ||
| Rallybio Corp | COM | 75120L100 | 3,886 | 268,532 | SH | SOLE | 268,532 | 0 | 0 | ||
| Relmada Therapeutics Inc | COM | 75955J402 | 56,198 | 1,518,056 | SH | SOLE | 1,518,056 | 0 | 0 | ||
| Savara Inc | COM | 805111101 | 7,060 | 4,555,038 | SH | SOLE | 4,555,038 | 0 | 0 | ||
| Terns Pharmaceuticals Inc | COM | 880881107 | 21,839 | 3,707,891 | SH | SOLE | 3,707,891 | 0 | 0 | ||
| Trevi Therapeutics Inc | COM | 89532M101 | 4,697 | 3,050,022 | SH | SOLE | 3,050,022 | 0 | 0 | ||
| Tricida Inc | COM | 89610F101 | 94,845 | 9,050,064 | SH | SOLE | 9,050,064 | 0 | 0 | ||
| Ventyx Biosciences Inc | COM | 92332V107 | 7,259 | 207,925 | SH | SOLE | 207,925 | 0 | 0 | ||
| Viridian Therapeutics Inc | COM | 92790C104 | 43,693 | 2,130,308 | SH | SOLE | 2,130,308 | 0 | 0 | ||